Chelsea Therapeutics Contingen's ticker is and the CUSIP is 163ESC908. A total of 2 filers reported holding Chelsea Therapeutics Contingen in Q3 2016. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2017 | $0 | – | 26,850 | 0.0% | 0.00% | – |
| Q2 2017 | $0 | – | 26,850 | +1.5% | 0.00% | – |
| Q4 2016 | $0 | – | 26,450 | -0.1% | 0.00% | – |
| Q3 2016 | $0 | – | 26,487 | 0.0% | 0.00% | – |
| Q2 2016 | $0 | – | 26,487 | 0.0% | 0.00% | – |
| Q1 2016 | $0 | – | 26,487 | -33.1% | 0.00% | – |
| Q2 2015 | $0 | – | 39,600 | -11.1% | 0.00% | – |
| Q4 2014 | $0 | – | 44,551 | 0.0% | 0.00% | – |
| Q3 2014 | $0 | – | 44,551 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| PARAMETRIC PORTFOLIO ASSOCIATES LLC | 26,487 | $0 | 0.00% |
| TOCQUEVILLE ASSET MANAGEMENT L.P. | 80,000 | $0 | 0.00% |